Disaster Lit® Database Daily Updates | COVID-19

Disaster Lit® Database Daily Updates

Coronavirus (COVID-19) Advice for the Health and Aged Care Sector

07/06/2020 12:00 AM EDT

Source: Australian Government. Published: 7/6/2020. This web page, updated on July 6, 2020, provides up-to-date and authoritative information and advice on COVID-19 for the health and aged care sector. (Text)

Investing In and Building Longer-Term Health Emergency Preparedness During the COVID-19 Pandemic: Interim Guidance for WHO Member States

07/06/2020 12:00 AM EDT

Source: World Health Organization (WHO). Published: 7/6/2020. This 30-page document is to help Member States build on actions taken during the COVID-19 pandemic to improve national medium- to long-term preparedness for future threats. It maps COVID-19 preparedness and response actions to the building of sustainable International Health Regulations (2005) core capacities; locates relevant supporting WHO resources that are not specific to the pandemic; and advocates for the conscious and effective allocation of COVID-19 funds to also meet countries’ longer-term needs. (PDF)

Information for Laboratories about Coronavirus (COVID-19)

07/03/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/3/2020. This web page provides COVID-19 resources for laboratories, including about diagnostics tests, CDC lab work, publications, and alerts and advisories. (Text)

Guidance on the Provision of Support for Medically and Socially Vulnerable Populations in EU/EEA Countries and the United Kingdom During the COVID-19 Pandemic: Technical Report

07/03/2020 12:00 AM EDT

Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 7/3/2020. The objective of this 36-page document is to provide guidance for civil society and non-governmental organizations (NGOs), as well as for national and regional authorities in the European Union and European Economic Area (EU/EEA) and the United Kingdom (UK), who are providing support for people who have medical and social vulnerabilities during the coronavirus disease (COVID-19) pandemic. (PDF)

Infection Prevention and Control and Surveillance for Coronavirus Disease (COVID-19) in Prisons in EU/EEA Countries and the UK: Technical Report

07/03/2020 12:00 AM EDT

Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 7/3/2020. This 20-page document provides principles of surveillance, infection prevention and control (IPC), and management of COVID-19 infection in prisons in European Union (EU) and European Economic Area (EEA) countries and the United Kingdom (UK). (PDF)

COVID-19 Epidemic Trends and Control Measures in Mainland China: Report 30

07/03/2020 12:00 AM EDT

Source: Imperial College London. Published: 7/3/2020. To understand the epidemic trends of COVID-19 in China, this 16-page report summarizes a study that carried out data collation and descriptive analysis in 31 provinces and municipalities, with a focus on the six most affected. (PDF)

Updated Information for Human Cell, Tissue, or Cellular or Tissue-based Product (HCT/P) Establishments Regarding the COVID-19 Pandemic

07/02/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 7/2/2020. This web page, updated on July 2, 2020, provides information about routine screening measures that are already in place for evaluating clinical evidence of infection in human cell, tissue, or cellular or tissue-based product (HCT/P) donors. To date, there have been no reported cases of transmission of COVID-19 via these products. FDA does not recommend using laboratory tests to screen asymptomatic HCT/P donors. (Text)

Interim Guidance on Testing Healthcare Personnel for SARS-CoV-2

07/02/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/2/2020. This web page provides a summary of considerations and current Centers for Disease Control and Prevention (CDC) recommendations regarding testing healthcare personnel (HCP) for SARS-CoV-2, which can be considered in four situations that are detailed. (Text)

COVID-19 Lecture: High Seroprevalence, Drastic Decline of Incidence and Low Infection Fatality Rate of SARS-CoV-2 Infections in Children and Adults in the Ski Resort Ischgl, Austria

07/01/2020 12:00 AM EDT

Source: National Institutes of Health (NIH). Published: 7/1/2020. This one-hour, two-minute presentation discusses a SARS-CoV-2 outbreak at a ski resort in Ischgl, Austria, that initiated the spread of SARS-CoV-2 throughout Austria and Northern Europe. Thousands of infections can be traced back to Ischgl. In a recent study by Medical University of Innsbruck investigators, 42.4 percent of those living in Ischgl were shown to be carrying the new coronavirus antibodies, indicating they had been infected in the COVID-19 pandemic. (Video or Multimedia)

Impact of the COVID-19 Epidemic on All-Cause Attendances to Emergency Departments in Two Large London Hospitals: An Observational Study: Report 29

07/01/2020 12:00 AM EDT

Source: Imperial College London. Published: 7/1/2020. This 32-page report assesses how the reorganization of hospital care and admission policies to respond to the COVID-19 epidemic affected emergency department attendances and emergency hospital admissions. (PDF)

Beyond COVID-19: A Whole of Health Look at Impacts During the Pandemic Response

07/01/2020 12:00 AM EDT

Source: Center for Global Development (CGD). Published: 7/1/2020. This 33-page paper provides an overview of the lessons learned from previous outbreaks and economic crises in relation to indirect health effects, as well as a framework for adopting a whole of health approach to the COVID response. This framework articulates indirect health impacts around four distinct but interrelated sets of impacts: economic, environmental, health systems, and social/behavioral. (PDF)

Operational Considerations for Immunization Services During COVID-19 in Non-U.S. Settings Focusing on Low-Middle Income Countries

06/30/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/30/2020. This web page provides operational considerations for the implementation of immunization services during the COVID-19 pandemic in non-U.S. settings. Its intended users are CDC country offices, immunization program managers, and staff from partner immunization programs. (Text)

Performing Broad-Based Testing for SARS-CoV-2 in Congregate Settings: Considerations for Health Departments and Healthcare Providers

06/27/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/27/2020. This guidance is intended to help public health departments and healthcare providers prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community, based on guidance for specific settings. (Text)

Coronavirus 2019 (COVID-19): People Who Are at Increased Risk for Severe Illness

06/25/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/25/2020. This web page, updated on June 25, 2020, discusses the people who are more likely than others to become severely ill from COVID-19, which means that they may require hospitalization, intensive care, or a ventilator to help them breathe, or they may even die. (Video or Multimedia)

After the Smoke Clears: How Wildfires Impact Our Health

06/24/2020 12:00 AM EDT

Source: American Public Health Association (APHA). Published: 6/24/2020. This one-hour webinar from the APHA Center for Climate, Health and Equity discusses wildfire smoke and its public health impacts, with a focus on health equity. Presenters describe the public health impacts of wildfire smoke; identify the ways in which climate change and health equity lead to disparate health risks for wildfire smoke exposure; and explore opportunities for building resilience and bolstering wildfire preparedness. (Video or Multimedia)

Investigating and Responding to COVID-19 Cases in Non-Healthcare Work Settings: Considerations for State and Local Health Departments

06/23/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/23/2020. Workplaces can present unique challenges for COVID-19 investigation and public health action. The tools on this web page can be used for responding to individual cases and outbreaks in non-healthcare work settings. (Text)

Webinar Series - Respirators for Health Care Personnel Use during COVID-19 Pandemic: Landing Page

06/07/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/7/2020. This web page provides information about a webinar series, starting on June 7, 2020, discussing the importation of respirators during the COVID-19 pandemic, and the Food and Drug Administration's collaboration with the Centers for Disease Control and Prevention on the sampling and testing of international respirators in support of the FDA's respirator Emergency Use Authorizations. (Text)

Information for Healthcare Professionals about Coronavirus (COVID-19)

06/01/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/1/2020. This web page provides information, tools, and guidance about COVID-19 for healthcare professionals, including about Care for Patients, Protect Patients and Workers, and Facility Guidance. (Text)